Exploring the role of the private sector in tuberculosis detection and management in Lima, Peru: a mixed-methods patient pathway analysis.


Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
29 Sep 2023
Historique:
pubmed: 9 10 2023
medline: 9 10 2023
entrez: 9 10 2023
Statut: epublish

Résumé

In Latin America, little is known about the involvement of private healthcare providers in TB detection and management. We sought to gain a better understanding of current and potential roles of the private sector in delivering TB services in Peru. We conducted a mixed-methods study in Lima, Peru. The quantitative component comprised a patient pathway analysis assessing the alignment of TB services with patient care-seeking behavior. The qualitative component comprised in-depth interviews with 18 private healthcare providers and 5 key informants. We estimated that 77% of patients initially sought care at a facility with TB diagnostic capacity and 59% at a facility with TB treatment capacity. The lack of TB services at initial care-seeking location was driven by the 41% of patients estimated to seek care first at a private facility. Among private facilities, 43% offered smear microscopy, 13% offered radiography, and none provided TB treatment. Among public sector facilities, 100% offered smear microscopy, 26% offered radiography, and 99% provided TB treatment. Interviews revealed that private providers believed that they offered shorter wait times and a quicker diagnosis, but they struggled with a lack of follow-up systems and communication barriers with the public sector. While expressing willingness to collaborate with public sector programs for diagnosis and referral, private providers had limited interest in treating TB. This study highlights the role of private providers in Peru as an entry point for TB care. Public-private collaboration is necessary to harness the potential of the private sector as an ally for early diagnosis.

Identifiants

pubmed: 37808756
doi: 10.1101/2023.09.27.23296252
pmc: PMC10557838
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIMHD NIH HHS
ID : DP2 MD015102
Pays : United States

Déclaration de conflit d'intérêts

Disclosures: The authors declare no conflicts of interest.

Auteurs

Christoph Wippel (C)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.

Sheyla Farroñay (S)

Socios En Salud Sucursal Perú, Lima, Perú.

Hannah N Gilbert (HN)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.

Ana Karina Millones (AK)

Socios En Salud Sucursal Perú, Lima, Perú.

Diana Acosta (D)

Socios En Salud Sucursal Perú, Lima, Perú.

Isabel Torres (I)

Socios En Salud Sucursal Perú, Lima, Perú.

Judith Jimenez (J)

Socios En Salud Sucursal Perú, Lima, Perú.

Leonid Lecca (L)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Socios En Salud Sucursal Perú, Lima, Perú.

Courtney M Yuen (CM)

Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA.

Classifications MeSH